Glenmark Pharmaceuticals Ltd., with headquarters in Mumbai, India, is planning to build a new manufacturing facility at Monroe Corporate Center in North Carolina. The facility will be spread over 100,000 sq. feet, or around 15 acre plot.
According to the company, it will first begin work on an oral solid unit and thereafter set up manufacturing units for injectables and topicals.
“Our plan to set up a new state-of-the-art manufacturing facility in the US underlines the fast-paced growth the company has witnessed in a short span of eight years in the US market and our long term commitment to the country,” said Glenn Saldanha, chairman and MD, Glenmark Pharmaceuticals Ltd.
“Over the next five years, we will make significant investments in this proposed facility and set up three units which will produce oral solids, injectables and topicals,” he added.